Variant report

Variant	nsv5458
Chromosome Location	chr6:121787521-121823054
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr6:121806302-121807135	A549	lung:	n/a	n/a
2	CBX3	chr6:121800552-121801209	HCT-116	colon:	n/a	n/a
3	CEBPB	chr6:121806404-121807266	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr6:121803179-121803808	IMR90	lung:	n/a	n/a
5	CEBPB	chr6:121800569-121801144	HCT-116	colon:	n/a	n/a
6	CEBPB	chr6:121803163-121803824	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr6:121806497-121807007	IMR90	lung:	n/a	n/a
8	CEBPB	chr6:121806349-121807198	A549	lung:	n/a	n/a
9	CEBPB	chr6:121803254-121803815	A549	lung:	n/a	n/a
10	CEBPB	chr6:121820093-121820198	A549	lung:	n/a	n/a
11	CEBPB	chr6:121806423-121807097	A549	lung:	n/a	n/a
12	CEBPB	chr6:121806376-121807084	A549	lung:	n/a	n/a
13	CEBPB	chr6:121805223-121805345	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr6:121796173-121796291	Medullo	brain:	n/a	n/a
15	CTCF	chr6:121815425-121815474	LNCaP	prostate:	n/a	n/a
16	E2F4	chr6:121791603-121791754	MCF10A-Er-Src	breast:	n/a	n/a
17	EP300	chr6:121806342-121807271	A549	lung:	n/a	n/a
18	EP300	chr6:121806414-121807064	Hela-S3	cervix:	n/a	n/a
19	EP300	chr6:121802996-121803660	SK-N-SH	brain:	n/a	chr6:121803084-121803091
20	EP300	chr6:121803075-121803524	Hela-S3	cervix:	n/a	chr6:121803084-121803091
21	EP300	chr6:121806256-121807152	A549	lung:	n/a	n/a
22	EP300	chr6:121803218-121803508	SK-N-SH_RA	brain:	n/a	n/a
23	FOS	chr6:121820203-121820325	MCF10A-Er-Src	breast:	n/a	chr6:121820240-121820247 chr6:121820240-121820248 chr6:121820239-121820249 chr6:121820239-121820248
24	FOS	chr6:121803125-121803794	MCF10A-Er-Src	breast:	n/a	chr6:121803280-121803291
25	FOS	chr6:121803040-121803815	MCF10A-Er-Src	breast:	n/a	chr6:121803280-121803291
26	FOS	chr6:121806426-121806702	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr6:121806385-121806744	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr6:121822453-121822459	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr6:121803081-121803660	HUVEC	blood vessel:	n/a	chr6:121803280-121803291
30	FOS	chr6:121806387-121806958	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr6:121806386-121807033	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr6:121803137-121803784	MCF10A-Er-Src	breast:	n/a	chr6:121803280-121803291
33	FOS	chr6:121820134-121820334	MCF10A-Er-Src	breast:	n/a	chr6:121820240-121820247 chr6:121820240-121820248 chr6:121820239-121820249 chr6:121820239-121820248
34	FOS	chr6:121802888-121803814	MCF10A-Er-Src	breast:	n/a	chr6:121803280-121803291
35	FOS	chr6:121812385-121812474	MCF10A-Er-Src	breast:	n/a	chr6:121812435-121812443
36	FOSL1	chr6:121800549-121801240	HCT-116	colon:	n/a	chr6:121800996-121801010
37	FOSL1	chr6:121800565-121801221	HCT-116	colon:	n/a	chr6:121800996-121801010
38	FOSL2	chr6:121819946-121820380	A549	lung:	n/a	chr6:121820240-121820247 chr6:121820240-121820248 chr6:121820239-121820249 chr6:121820239-121820248
39	FOSL2	chr6:121800573-121801079	A549	lung:	n/a	chr6:121800996-121801010
40	FOSL2	chr6:121803008-121803581	A549	lung:	n/a	n/a
41	FOSL2	chr6:121803171-121803428	A549	lung:	n/a	n/a
42	FOSL2	chr6:121806298-121807060	A549	lung:	n/a	n/a
43	FOSL2	chr6:121803005-121803607	SK-N-SH	brain:	n/a	n/a
44	FOSL2	chr6:121820143-121820351	A549	lung:	n/a	chr6:121820240-121820247 chr6:121820240-121820248 chr6:121820239-121820249 chr6:121820239-121820248
45	FOSL2	chr6:121803152-121803462	SK-N-SH	brain:	n/a	n/a
46	FOXA2	chr6:121806422-121806885	A549	lung:	n/a	n/a
47	FOXA2	chr6:121801305-121801651	A549	lung:	n/a	n/a
48	GATA3	chr6:121803025-121803644	SK-N-SH	brain:	n/a	n/a
49	GATA3	chr6:121806262-121807255	A549	lung:	n/a	chr6:121806376-121806393
50	GATA3	chr6:121806328-121807080	A549	lung:	n/a	chr6:121806376-121806393

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:121801389-121801439	AG09319	gingival:	n/a
2	chr6:121801389-121801439	AG10803	skin:	n/a
3	chr6:121801389-121801439	AG09319	gingival:	n/a
4	chr6:121801389-121801439	AG10803	skin:	n/a
5	chr6:121801389-121801439	CMK	blood:	n/a
6	chr6:121801389-121801439	Hela-S3	cervix:	n/a
7	chr6:121801389-121801439	MCF10A-Er-Src	breast:	n/a
8	chr6:121801389-121801439	HNPCEpiC	eye:	n/a
9	chr6:121801389-121801439	AG04449	skin:	fetal
10	chr6:121801389-121801439	HCM	heart:	n/a
11	chr6:121801389-121801439	ovcar-3	ovarian:	n/a
12	chr6:121801389-121801439	HCF	heart:	n/a
13	chr6:121801389-121801439	U87	brain:	n/a
14	chr6:121801389-121801439	HCPEpiC	choroid plexus:	n/a
15	chr6:121801389-121801439	PANC-1	pancreas:	n/a
16	chr6:121801389-121801439	MCF-7	breast:	n/a
17	chr6:121801389-121801439	A549	lung:	n/a
18	chr6:121801389-121801439	GM12878	blood:	n/a
19	chr6:121801389-121801439	GM12892	blood:	n/a
20	chr6:121801389-121801439	NH-A	brain:	n/a
21	chr6:121801389-121801439	HUVEC	blood vessel:	n/a
22	chr6:121801389-121801439	HEEpiC	esophagus:	n/a
23	chr6:121801389-121801439	HIPEpiC	eye:	n/a
24	chr6:121801389-121801439	AG09309	skin:	n/a
25	chr6:121801389-121801439	HRCEpiC	kidney:	n/a
26	chr6:121801389-121801439	NT2-D1	testis:	n/a
27	chr6:121801389-121801439	AoSMC	blood vessel:	n/a
28	chr6:121801389-121801439	NB4	blood:	n/a
29	chr6:121801389-121801439	HCT-116	colon:	n/a
30	chr6:121801389-121801439	HAEpiC	amniotic membrane:	n/a
31	chr6:121801389-121801439	ECC-1	luminal epithelium:	n/a
32	chr6:121801389-121801439	SKMC	muscle:	n/a
33	chr6:121801389-121801439	T-47D	breast:	n/a
34	chr6:121801389-121801439	SK-N-SH_RA	brain:	n/a
35	chr6:121801389-121801439	IMR90	lung:	fetal
36	chr6:121801389-121801439	NHDF-neo	bronchial:	n/a
37	chr6:121801389-121801439	Jurkat	blood:	n/a
38	chr6:121801389-121801439	HMEC	breast:	n/a
39	chr6:121801389-121801439	SK-N-SH	brain:	n/a
40	chr6:121801389-121801439	PrEC	prostate:	n/a
41	chr6:121801389-121801439	RPTEC	kidney:	n/a
42	chr6:121801389-121801439	Hepatocyte	liver:	n/a
43	chr6:121801389-121801439	PFSK-1	brain:	n/a
44	chr6:121801389-121801439	GM19239	blood:	n/a
45	chr6:121801389-121801439	HepG2	liver:	n/a
46	chr6:121801389-121801439	NHBE	bronchial:	n/a
47	chr6:121801389-121801439	GM12891	blood:	n/a
48	chr6:121801389-121801439	LNCaP	prostate:	n/a
49	chr6:121801389-121801439	K562	blood:	n/a
50	chr6:121801389-121801439	SAEC	small airway:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:18962334..18963136-chr6:121821481..121822051,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C6orf170-1	chr6:121799842-121800029	NONHSAT114737
2	lnc-C6orf170-1	chr6:121800359-121800539	NONHSAT114737
3	lnc-C6orf170-1	chr6:121800864-121801054	NONHSAT114737
4	lnc-C6orf170-1	chr6:121799419-121799522	NONHSAT114737

Variant related genes	Relation type
ENSG00000219784	TF binding region
ENSG00000219784	CpG island

Extended variants
information (count: 925 )
Associated
traits (count: 114 )

Variant overlapped rSNPs/rCNVs (count:925 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs138254009	chr6:121799422-121799423	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
2	rs536917797	chr6:121799436-121799437	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
3	rs542906007	chr6:121799846-121799847	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs564837004	chr6:121799911-121799912	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
5	rs527344120	chr6:121799928-121799929	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
6	rs540689589	chr6:121799968-121799969	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
7	rs191979241	chr6:121799980-121799981	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
8	rs560895616	chr6:121800000-121800001	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
9	rs529760361	chr6:121800473-121800474	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
10	rs181253417	chr6:121800474-121800475	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
11	rs563982307	chr6:121800499-121800500	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
12	rs12198502	chr6:121800620-121800621	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs552519101	chr6:121800631-121800632	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs535914272	chr6:121800653-121800654	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs528665708	chr6:121800724-121800725	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs548317870	chr6:121800763-121800764	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs145440511	chr6:121800779-121800780	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs185073961	chr6:121800784-121800785	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs188203465	chr6:121800796-121800797	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs148828675	chr6:121800800-121800801	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs534481736	chr6:121800824-121800825	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs538948836	chr6:121800851-121800852	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs558555802	chr6:121800857-121800858	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs143484294	chr6:121800889-121800890	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
25	rs180998656	chr6:121800900-121800901	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
26	rs148014677	chr6:121800909-121800910	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
27	rs548087579	chr6:121800958-121800959	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
28	rs543459131	chr6:121800959-121800960	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
29	rs368818063	chr6:121800973-121800974	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
30	rs78793803	chr6:121800974-121800975	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs146847172	chr6:121800975-121800976	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs559789543	chr6:121800987-121800988	Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
33	rs186319480	chr6:121801002-121801003	Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs572956913	chr6:121801043-121801044	Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
35	rs537228975	chr6:121801048-121801049	Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs10214454	chr6:121801055-121801056	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs561860777	chr6:121801102-121801103	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs530881649	chr6:121801164-121801165	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs73767028	chr6:121801171-121801172	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs73532274	chr6:121801185-121801186	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs10214457	chr6:121801229-121801230	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs139343194	chr6:121801322-121801323	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs9375034	chr6:121801368-121801369	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs386705337	chr6:121801377-121801378	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs9398635	chr6:121801379-121801380	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs35674549	chr6:121801415-121801416	Enhancers Weak transcription Active TSS	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs537171520	chr6:121801420-121801421	Enhancers Weak transcription Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs191116084	chr6:121801431-121801432	Enhancers Weak transcription Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs576815805	chr6:121801444-121801445	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs17654076	chr6:121801471-121801472	Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:114)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	22495311	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
T-cell lymphomas	19863542	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Urothelial carcinoma	18382360	CNVD
Ovarian neoplasms	16753589	CNVD
Hepatocellular carcinoma	16750200	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	19242612	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Developmental delay	19490664	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Burkitt''s lymphoma	18698080	CNVD
Ovarian cancer	21720365	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	16461572	CNVD
Neurocytoma	17123091	CNVD
Breast cancer	21364760	CNVD
Chordoma	21602918	CNVD
Kartagener syndrome	16639409	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17133270	CNVD
Follicular lymphoma	18703704	CNVD
Mental retardation	17621639	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Metastatic melanoma	18483359	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Breast cancer	18698023	CNVD
Mental retardation	18854857	CNVD
Leukemia	18688285	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Liver carcinoma	19366792	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Ependymoma	18628472	CNVD
Ewing''s sarcoma	18628472	CNVD
Leukemia	18628472	CNVD
Breast cancer	21611746	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Ovarian cancer	21781307	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Adenoid cystic carcinoma	18332873	CNVD

Chromatin state (count:198 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:121800600-121801200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr6:121800600-121801200	Enhancers	Placenta	Placenta
3	chr6:121800800-121801000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr6:121800800-121801800	Active TSS	A549	lung
5	chr6:121800800-121802000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
6	chr6:121801000-121801200	Enhancers	Placenta Amnion	Placenta Amnion
7	chr6:121801000-121801200	Enhancers	Hela-S3	cervix
8	chr6:121801000-121801600	Enhancers	HUES6 Cell Line	embryonic stem cell
9	chr6:121801000-121803200	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr6:121801000-121806200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr6:121801200-121803600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr6:121801600-121806200	Weak transcription	HUES6 Cell Line	embryonic stem cell
13	chr6:121801800-121802000	Enhancers	Placenta Amnion	Placenta Amnion
14	chr6:121801800-121802800	Weak transcription	Hela-S3	cervix
15	chr6:121801800-121803400	Enhancers	A549	lung
16	chr6:121802000-121803200	Enhancers	NHEK	skin
17	chr6:121802400-121802600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr6:121802400-121803000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr6:121802400-121803000	Enhancers	HMEC	breast
20	chr6:121802400-121803600	Enhancers	HUES48 Cell Line	embryonic stem cell
21	chr6:121802600-121803000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr6:121802600-121804000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr6:121802600-121804000	Enhancers	HUVEC	blood vessel
24	chr6:121802600-121808600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr6:121802800-121803200	Enhancers	Muscle Satellite Cultured Cells	--
26	chr6:121802800-121803200	Enhancers	Hela-S3	cervix
27	chr6:121802800-121803800	Enhancers	HSMM	muscle
28	chr6:121803000-121803200	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr6:121803000-121803400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr6:121803000-121803400	Enhancers	NH-A	brain
31	chr6:121803000-121803400	Enhancers	NHDF-Ad	bronchial
32	chr6:121803000-121804000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
33	chr6:121803000-121806000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
34	chr6:121803000-121806200	Weak transcription	HMEC	breast
35	chr6:121803200-121805600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
36	chr6:121803200-121806200	Weak transcription	Muscle Satellite Cultured Cells	--
37	chr6:121803200-121806200	Weak transcription	NHEK	skin
38	chr6:121803200-121806400	Weak transcription	Hela-S3	cervix
39	chr6:121803400-121805400	Weak transcription	A549	lung
40	chr6:121803400-121806400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr6:121803600-121803800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr6:121803600-121805600	Weak transcription	HUES48 Cell Line	embryonic stem cell
43	chr6:121803800-121804600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr6:121804000-121806000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr6:121804000-121806400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr6:121805000-121805200	Enhancers	iPS-18 Cell Line	embryonic stem cell
47	chr6:121805000-121807400	Enhancers	HUES64 Cell Line	embryonic stem cell
48	chr6:121805200-121806200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
49	chr6:121805400-121806200	Enhancers	A549	lung
50	chr6:121805600-121805800	Enhancers	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links